Skip to content
2000
Volume 1, Issue 3
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Intravenous Immunoglobulin (IVIG) has been used since the 1970's for the treatment of a variety of different rheumatologic and infectious diseases. While the therapeutic efficacy of IVIG has been definitively demonstrated in many different disorders, its mechanism(s) of action have remained poorly explained. This is complicated, in part by the difference in pathophysiology of the many diseases it has been used in the treatment of. Regardless of the types of diseases, understanding why transfusing pooled donor antibodies to unscreened patients fails to elicit a detrimental immunologic response, let alone benefit these patients, needs explanation. This review aims to explain how IVIG works by reviewing the medical literature and the relevant basic immunology involved.

Loading

Article metrics loading...

/content/journals/crr/10.2174/157339705774612355
2005-11-01
2025-05-20
Loading full text...

Full text loading...

/content/journals/crr/10.2174/157339705774612355
Loading

  • Article Type:
    Review Article
Keyword(s): autoimmunity; immunoglobulin; immunology; IVIG; mechanism; rheumatic
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test